Suppr超能文献

人细胞色素 P450 芳香酶关键残基功能作用的结构基础。

Structural basis for the functional roles of critical residues in human cytochrome p450 aromatase.

机构信息

Department of Pharmacology, SUNY Upstate Medical University, Syracuse, New York 13210, United States.

出版信息

Biochemistry. 2013 Aug 27;52(34):5821-9. doi: 10.1021/bi400669h. Epub 2013 Aug 16.

Abstract

Cytochrome P450 aromatase (CYP19A1) is the only enzyme known to catalyze the biosynthesis of estrogens from androgens. The crystal structure of human placental aromatase (pArom) has paved the way toward understanding the structure-function relationships of this remarkable enzyme. Using an amino terminus-truncated recombinant human aromatase (rArom) construct, we investigate the roles of key amino acids in the active site, at the intermolecular interface, inside the access channel, and at the lipid-protein boundary for their roles in enzyme function and higher-order organization. Replacing the active site residue D309 with an N yields an inactive enzyme, consistent with its proposed involvement in aromatization. Mutation of R192 at the lipid interface, pivotal to the proton relay network in the access channel, results in the loss of enzyme activity. In addition to the distal catalytic residues, we show that mutation of K440 and Y361 of the heme-proximal region critically interferes with substrate binding, enzyme activity, and heme stability. The D-E loop deletion mutant Del7 that disrupts the intermolecular interaction significantly reduces enzyme activity. However, the less drastic Del4 and point mutants E181A and E181K do not. Furthermore, native gel electrophoresis, size-exclusion chromatography, and analytical ultracentrifugation are used to show that mutations in the intermolecular interface alter the quaternary organization of the enzyme in solution. As a validation for interpretation of the mutational results in the context of the innate molecule, we determine the crystal structure of rArom to show that the active site, tertiary, and quaternary structures are identical to those of pArom.

摘要

细胞色素 P450 芳香酶(CYP19A1)是唯一已知能催化雄激素转化为雌激素的酶。人胎盘芳香酶(pArom)的晶体结构为理解这种非凡酶的结构-功能关系铺平了道路。使用截断的重组人芳香酶(rArom)构建体,我们研究了关键氨基酸在活性部位、分子间界面、进入通道内部和脂质-蛋白边界的作用,以了解它们在酶功能和高级结构组织中的作用。用 N 替换活性部位残基 D309 会产生无活性的酶,这与它在芳香化中的作用一致。位于脂质界面的关键氨基酸 R192 的突变,对进入通道中的质子传递网络至关重要,导致酶失活。除了远端催化残基外,我们还表明,位于血红素近端区域的 K440 和 Y361 的突变严重干扰了底物结合、酶活性和血红素稳定性。破坏分子间相互作用的 D-E 环缺失突变 Del7 显著降低了酶活性。然而,程度较轻的 Del4 和点突变 E181A 和 E181K 则不会。此外,还使用Native gel electrophoresis、size-exclusion chromatography 和 analytical ultracentrifugation 来表明,分子间界面的突变会改变酶在溶液中的四级结构。为了验证在天然分子背景下对突变结果的解释,我们确定了 rArom 的晶体结构,以显示活性部位、三级和四级结构与 pArom 相同。

相似文献

1
Structural basis for the functional roles of critical residues in human cytochrome p450 aromatase.
Biochemistry. 2013 Aug 27;52(34):5821-9. doi: 10.1021/bi400669h. Epub 2013 Aug 16.
2
Higher order organization of human placental aromatase.
Steroids. 2011 Jul;76(8):753-8. doi: 10.1016/j.steroids.2011.02.030. Epub 2011 Mar 8.
3
Motion and flexibility in human cytochrome p450 aromatase.
PLoS One. 2012;7(2):e32565. doi: 10.1371/journal.pone.0032565. Epub 2012 Feb 27.
4
Testosterone complex and non-steroidal ligands of human aromatase.
J Steroid Biochem Mol Biol. 2018 Jul;181:11-19. doi: 10.1016/j.jsbmb.2018.02.009. Epub 2018 Feb 21.
5
Binding features of steroidal and nonsteroidal inhibitors.
Steroids. 2011 Jul;76(8):802-6. doi: 10.1016/j.steroids.2011.02.037. Epub 2011 Mar 21.
6
Structural determinants of aromatase cytochrome p450 inhibition in substrate recognition site-1.
Mol Endocrinol. 2002 Jul;16(7):1456-68. doi: 10.1210/mend.16.7.0876.
7
Structural basis for androgen specificity and oestrogen synthesis in human aromatase.
Nature. 2009 Jan 8;457(7226):219-23. doi: 10.1038/nature07614.
8
Molecular basis for the aromatization reaction and exemestane-mediated irreversible inhibition of human aromatase.
Mol Endocrinol. 2007 Feb;21(2):401-14. doi: 10.1210/me.2006-0281. Epub 2006 Nov 9.
9
Phosphorylation of human placental aromatase CYP19A1.
Biochem J. 2019 Nov 15;476(21):3313-3331. doi: 10.1042/BCJ20190633.
10
Molecular and Structural Evolution of Cytochrome P450 Aromatase.
Int J Mol Sci. 2021 Jan 10;22(2):631. doi: 10.3390/ijms22020631.

引用本文的文献

2
Integrated Virtual Screening Approach Identifies New CYP19A1 Inhibitors.
J Chem Inf Model. 2025 Apr 14;65(7):3529-3543. doi: 10.1021/acs.jcim.5c00204. Epub 2025 Mar 19.
4
Effect of Essential Oil Components on the Activity of Steroidogenic Cytochrome P450.
Biomolecules. 2024 Feb 8;14(2):203. doi: 10.3390/biom14020203.
5
Charged Amino Acids in the Transmembrane Helix Strongly Affect the Enzyme Activity of Aromatase.
Int J Mol Sci. 2024 Jan 24;25(3):1440. doi: 10.3390/ijms25031440.
6
Generation of human steroidogenic cytochrome P450 enzymes for structural and functional characterization.
Methods Enzymol. 2023;689:3-38. doi: 10.1016/bs.mie.2023.05.010. Epub 2023 Jun 12.
7
Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research.
Drug Metab Dispos. 2023 Jun;51(6):685-699. doi: 10.1124/dmd.122.001008. Epub 2023 Mar 22.
9
Mechanisms of allosteric and mixed mode aromatase inhibitors.
RSC Chem Biol. 2021 Mar 19;2(3):892-905. doi: 10.1039/d1cb00046b. eCollection 2021 Jun 1.

本文引用的文献

1
Human aromatase: perspectives in biochemistry and biotechnology.
Biotechnol Appl Biochem. 2013 Jan-Feb;60(1):92-101. doi: 10.1002/bab.1088.
2
Coupled electron transfer and proton hopping in the final step of CYP19-catalyzed androgen aromatization.
Biochemistry. 2012 Apr 10;51(14):3039-49. doi: 10.1021/bi300017p. Epub 2012 Mar 27.
3
Motion and flexibility in human cytochrome p450 aromatase.
PLoS One. 2012;7(2):e32565. doi: 10.1371/journal.pone.0032565. Epub 2012 Feb 27.
4
Higher order organization of human placental aromatase.
Steroids. 2011 Jul;76(8):753-8. doi: 10.1016/j.steroids.2011.02.030. Epub 2011 Mar 8.
5
Efficient expression of human aromatase (CYP19) in E. coli.
Methods Mol Biol. 2011;705:109-22. doi: 10.1007/978-1-61737-967-3_7.
7
X-ray structure of human aromatase reveals an androgen-specific active site.
J Steroid Biochem Mol Biol. 2010 Feb 28;118(4-5):197-202. doi: 10.1016/j.jsbmb.2009.09.012. Epub 2009 Oct 4.
8
Rapid estradiol/ERalpha signaling enhances aromatase enzymatic activity in breast cancer cells.
Mol Endocrinol. 2009 Oct;23(10):1634-45. doi: 10.1210/me.2009-0039. Epub 2009 Jun 25.
9
History of aromatase: saga of an important biological mediator and therapeutic target.
Endocr Rev. 2009 Jun;30(4):343-75. doi: 10.1210/er.2008-0016. Epub 2009 Apr 23.
10
Molecular characterization of aromatase.
Ann N Y Acad Sci. 2009 Feb;1155:112-20. doi: 10.1111/j.1749-6632.2009.03703.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验